<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-16T21:30:50+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>联盟喜讯｜知名投资机构联手投资2.8亿元，创新药新锐众生睿创完成B轮融资</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/ESYZJwXQgmpL6L0jreze6A</id>
    <link href="https://mp.weixin.qq.com/s/ESYZJwXQgmpL6L0jreze6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东再签NASH领域新合作，刚上市的Aligos凭借拿手绝活寡核苷酸药物获得青睐</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/cNpH-agFfwHoDLnMMPhwmQ</id>
    <link href="https://mp.weixin.qq.com/s/cNpH-agFfwHoDLnMMPhwmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>骨髓瘤治疗新进展，全新作用机制药物Selinexor（ATG-010）三种治疗方案入选最新版NCCN®多发性骨髓瘤诊疗指南</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/_ArBzQPDvCh_2JDt88l7YQ</id>
    <link href="https://mp.weixin.qq.com/s/_ArBzQPDvCh_2JDt88l7YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>按图索骥？Nature封面研究：科学家们摸清了人类癌细胞的转移路线</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/efcnhzSAbcs5voHAjkhOHQ</id>
    <link href="https://mp.weixin.qq.com/s/efcnhzSAbcs5voHAjkhOHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>运气or天才：从DMSO到抗癌药伏立诺他的传奇之路</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/LNHxHklnvkaEj6aLZ6KNBA</id>
    <link href="https://mp.weixin.qq.com/s/LNHxHklnvkaEj6aLZ6KNBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制药公司因疫情获得的巨额融资是否能转化为更多新药？</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/SIrzY3wZwdwrNv0BBtcuyw</id>
    <link href="https://mp.weixin.qq.com/s/SIrzY3wZwdwrNv0BBtcuyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代，我们帮您找到理想的合作伙伴！</title>
    <updated>2020-12-16T06:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/BYx62biteEjFPJ4AHAg3lw</id>
    <link href="https://mp.weixin.qq.com/s/BYx62biteEjFPJ4AHAg3lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CRISPR编辑过的CAR-T在白血病模型中显现增强的活性</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/TXteehQ7_o3T7kTTS-VNQg</id>
    <link href="https://mp.weixin.qq.com/s/TXteehQ7_o3T7kTTS-VNQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业与阿尔脉生物就创新药研发达成战略合作</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/e3cL5oAGuyicYv5B6PTYmA</id>
    <link href="https://mp.weixin.qq.com/s/e3cL5oAGuyicYv5B6PTYmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>颠覆式创新：小分子PD-L1抑制剂能否破解PPI靶点成药难题？</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/D1F57m6S2URLAaQxfj1Ogg</id>
    <link href="https://mp.weixin.qq.com/s/D1F57m6S2URLAaQxfj1Ogg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>祝贺恒瑞！国家药监局批准PARP抑制剂氟唑帕利胶囊（商品名：艾瑞颐）上市</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/tFdc7HA_7Ofksa3NEdAA5Q</id>
    <link href="https://mp.weixin.qq.com/s/tFdc7HA_7Ofksa3NEdAA5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅药物发现之——恩格列净</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/0ADSmYg4Hjr6urF022ycUw</id>
    <link href="https://mp.weixin.qq.com/s/0ADSmYg4Hjr6urF022ycUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DrugTimes, We Help You Find Partners in China!</title>
    <updated>2020-12-15T07:47:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/tB2vGdDN4PcKMvkbm3pzXw</id>
    <link href="https://mp.weixin.qq.com/s/tB2vGdDN4PcKMvkbm3pzXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投稿 | 390亿美元收购亚力兄！布局罕见病领域，阿斯利康运筹帷幄大棋局</title>
    <updated>2020-12-14T08:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/w6uzc0j6lRMfwkXBWgy3wA</id>
    <link href="https://mp.weixin.qq.com/s/w6uzc0j6lRMfwkXBWgy3wA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>蓦然回首，灯火阑珊处 | 如何看待肿瘤新药？</title>
    <updated>2020-12-14T08:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/zs7H2DPQ2BIKgMQQ-SlzYA</id>
    <link href="https://mp.weixin.qq.com/s/zs7H2DPQ2BIKgMQQ-SlzYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿尔茨海默症 | 是否能在早期阻止“记忆橡皮擦”偷走我们的记忆？</title>
    <updated>2020-12-14T08:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/MPCQiVS4kZnXhgb3DqEIDQ</id>
    <link href="https://mp.weixin.qq.com/s/MPCQiVS4kZnXhgb3DqEIDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多发性骨髓瘤中国市场潜力达300亿元，多款创新药物布局蓝海市场</title>
    <updated>2020-12-14T08:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/5u3YdE84fVkRcBWyofLSeA</id>
    <link href="https://mp.weixin.qq.com/s/5u3YdE84fVkRcBWyofLSeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代诚聘英才，居家办公，共筑健康天下！</title>
    <updated>2020-12-14T08:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/fQBjxB5zjXC390uqpVbu7Q</id>
    <link href="https://mp.weixin.qq.com/s/fQBjxB5zjXC390uqpVbu7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>艾伯维公布Rinvoq的最新数据，Rinvoq能否顺利接棒Humira？</title>
    <updated>2020-12-12T09:00:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/e5Gd8pF2x_XWHACd4EZA-w</id>
    <link href="https://mp.weixin.qq.com/s/e5Gd8pF2x_XWHACd4EZA-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚被批准用于儿科SLE患者，贝利尤单抗在华又递交新适应症上市申请</title>
    <updated>2020-12-12T09:00:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/IPYGlMI0S7SXrdR5NuUGjg</id>
    <link href="https://mp.weixin.qq.com/s/IPYGlMI0S7SXrdR5NuUGjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>